What strategies can be used to mitigate hyperkalemia in CKD patients receiving RASi?
Strategies to control chronic hyperkalemia include dietary potassium restriction; discontinuation of potassium supplements, certain salt substitutes, and hyperkalemic drugs; adding potassium-wasting diuretics, and oral potassium binders.44 In CKD patients receiving RASi who develop hyperkalemia, the latter can be controlled with newer oral potassium binders in many patients, with the effect that RASi can be continued at the recommended dose.